July 27, 2023 09:05 AM EDT
Bioregnum

As SQZ faced a fi­nal reck­on­ing, a fate­ful board de­ci­sion steered the com­pa­ny to a quick and bru­tal endgame

A decade af­ter SQZ was birthed amid con­sid­er­able en­thu­si­asm and mid­wifed by one of the biggest sci­en­tif­ic stars in Cam­bridge, MA, the few sur­vivors of …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

End­points 100 biotech sur­vey: Wel­come to the sum­mer of biotech’s dis­con­tent

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times